Transparency in Canadian public drug advisory committees

Highlights • Most committees have some mechanisms to address transparency. • None of the committees had a fully transparent process. • Some steps to increase transparency can be implemented rapidly. • Increased transparency will lead to better decisions.

Saved in:

Bibliographic Details
Published in:	Health policy (Amsterdam) Vol. 118; no. 2; pp. 255 - 263
Main Authors:	Rosenberg-Yunger, Zahava R.S, Bayoumi, Ahmed M
Format:	Journal Article
Language:	English
Published:	Amsterdam Elsevier Ireland Ltd 01-11-2014 Elsevier
Subjects:	Access to Information Adult Advisory Committees - organization & administration Advisory Committees - standards Aged Biological and medical sciences Canada Canadians Communication Conflict Conflict of Interest Disclosure Drug policy Drugs Female Formularies as Topic Health administration Health care Health policy Humans Internal Medicine Interviewing Interviews as Topic Male Medical sciences Medical service Membership Middle Aged Miscellaneous Public access Public health. Hygiene Public health. Hygiene-occupational medicine Qualitative analysis Qualitative Research Regulation Resource allocation Resources allocation Transparency Canada North America America Qualitative research Resources allocation Transparency Drug policy Drug Health policy Financing Resource allocation Qualitative analysis Public health
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights • Most committees have some mechanisms to address transparency. • None of the committees had a fully transparent process. • Some steps to increase transparency can be implemented rapidly. • Increased transparency will lead to better decisions.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0168-8510 1872-6054
DOI:	10.1016/j.healthpol.2014.08.010